Dec 4, 2009 - ICON plc, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
The details can be read here.
No comments:
Post a Comment